• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For November 14, 2023

    11/14/23 8:23:43 AM ET
    $XNET
    $YTEN
    $CVAC
    $CMCL
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $XNET alert in real time by email

    Companies Reporting Before The Bell

    • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.

    • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its third quarter.

    • Argo Blockchain (NASDAQ:ARBK) is estimated to report quarterly loss at $0.12 per share on revenue of $13.28 million.

    • SuperCom (NASDAQ:SPCB) is estimated to report quarterly earnings at $0.00 per share on revenue of $4.60 million.

    • Moving iMage Technologies (AMEX:MITQ) is projected to report earnings for its first quarter.

    • Eagle Pharmaceuticals (NASDAQ:EGRX) is likely to report quarterly earnings at $1.06 per share on revenue of $62.60 million.

    • 2seventy bio (NASDAQ:TSVT) is estimated to report quarterly loss at $0.97 per share on revenue of $35.18 million.

    • Laser Photonics (NASDAQ:LASE) is expected to report earnings for its third quarter.

    • Palatin Techs (AMEX:PTN) is likely to report quarterly loss at $0.41 per share on revenue of $5.68 million.

    • Allego (NYSE:ALLG) is estimated to report earnings for its third quarter.

    • Vitru (NASDAQ:VTRU) is expected to report quarterly earnings at $0.25 per share on revenue of $94.04 million.

    • Data Storage (NASDAQ:DTST) is expected to report earnings for its third quarter.

    • Tingo Group (NASDAQ:TIO) is likely to report quarterly earnings at $0.46 per share on revenue of $1.26 billion.

    • Trevena (NASDAQ:TRVN) is likely to report quarterly loss at $0.15 per share on revenue of $100 thousand.

    • Magic Software (NASDAQ:MGIC) is estimated to report quarterly earnings at $0.27 per share on revenue of $146.40 million.

    • Jaguar Health (NASDAQ:JAGX) is likely to report quarterly loss at $1.23 per share on revenue of $2.46 million.

    • Immunic (NASDAQ:IMUX) is projected to report earnings for its third quarter.

    • Brainstorm Cell (NASDAQ:BCLI) is expected to report earnings for its third quarter.

    • Vipshop Holdings (NYSE:VIPS) is projected to report earnings for its third quarter.

    • Beam Glb (NASDAQ:BEEM) is expected to report quarterly loss at $0.32 per share on revenue of $16.27 million.

    • Crown ElectroKinetics (NASDAQ:CRKN) is projected to report earnings for its third quarter.

    • SPAR Group (NASDAQ:SGRP) is estimated to report quarterly earnings at $0.01 per share on revenue of $68.00 million.

    • TriSalus Life Sciences (NASDAQ:TLSI) is projected to report earnings for its third quarter.

    • Iterum Therapeutics (NASDAQ:ITRM) is expected to report earnings for its third quarter.

    • Ondas Holdings (NASDAQ:ONDS) is estimated to report quarterly loss at $0.17 per share on revenue of $3.08 million.

    • ReWalk Robotics (NASDAQ:RWLK) is projected to report quarterly loss at $0.11 per share on revenue of $4.30 million.

    • Syros Pharmaceuticals (NASDAQ:SYRS) is likely to report quarterly loss at $1.14 per share on revenue of $3.94 million.

    • Renalytix (NASDAQ:RNLX) is expected to report earnings for its first quarter.

    • Predictive Oncology (NASDAQ:POAI) is expected to report earnings for its third quarter.

    • Affimed (NASDAQ:AFMD) is likely to report quarterly loss at $0.20 per share on revenue of $2.01 million.

    • Advent Technologies Hldgs (NASDAQ:ADN) is projected to report earnings for its third quarter.

    • Imunon (NASDAQ:IMNN) is expected to report earnings for its third quarter.

    • PDS Biotechnology (NASDAQ:PDSB) is likely to report earnings for its third quarter.

    • UroGen Pharma (NASDAQ:URGN) is estimated to report quarterly loss at $0.85 per share on revenue of $20.03 million.

    • Xunlei (NASDAQ:XNET) is likely to report earnings for its third quarter.

    • DecisionPoint Sys (AMEX:DPSI) is likely to report quarterly earnings at $0.07 per share on revenue of $28.20 million.

    • Galera Therapeutics (NASDAQ:GRTX) is estimated to report earnings for its third quarter.

    • CAE (NYSE:CAE) is estimated to report quarterly earnings at $0.14 per share on revenue of $775.05 million.

    • Camtek (NASDAQ:CAMT) is projected to report quarterly earnings at $0.48 per share on revenue of $78.17 million.

    • BioXcel Therapeutics (NASDAQ:BTAI) is expected to report quarterly loss at $1.31 per share on revenue of $670 thousand.

    • iSun (NASDAQ:ISUN) is expected to report quarterly loss at $0.04 per share on revenue of $26.68 million.

    • Workhorse Gr (NASDAQ:WKHS) is projected to report quarterly loss at $0.12 per share on revenue of $20.94 million.

    • Sonida Senior Living (NYSE:SNDA) is likely to report earnings for its third quarter.

    • Luna Innovations (NASDAQ:LUNA) is likely to report quarterly earnings at $0.07 per share on revenue of $30.61 million.

    • Hut 8 Mining (NASDAQ:HUT) is estimated to report quarterly loss at $0.06 per share on revenue of $22.21 million.

    • Hyzon Motors (NASDAQ:HYZN) is likely to report earnings for its third quarter.

    • GreenPower Motor Co (NASDAQ:GP) is likely to report quarterly loss at $0.10 per share on revenue of $17.55 million.

    • FiscalNote Holdings (NYSE:NOTE) is expected to report quarterly loss at $0.16 per share on revenue of $34.61 million.

    • Eneti (NYSE:NETI) is likely to report quarterly earnings at $0.27 per share on revenue of $48.74 million.

    • Kanzhun (NASDAQ:BZ) is estimated to report earnings for its third quarter.

    • IHS Holding (NYSE:IHS) is expected to report quarterly earnings at $0.04 per share on revenue of $457.87 million.

    • Gamida Cell (NASDAQ:GMDA) is estimated to report quarterly loss at $0.17 per share on revenue of $2.37 million.

    • WalkMe (NASDAQ:WKME) is likely to report quarterly loss at $0.01 per share on revenue of $67.09 million.

    • Sally Beauty Holdings (NYSE:SBH) is likely to report quarterly earnings at $0.46 per share on revenue of $930.45 million.

    • Stronghold Digital Mining (NASDAQ:SDIG) is projected to report quarterly loss at $0.27 per share on revenue of $24.06 million.

    • Canadian Solar (NASDAQ:CSIQ) is likely to report quarterly earnings at $0.82 per share on revenue of $2.03 billion.

    • Alithya Group (NASDAQ:ALYA) is estimated to report earnings for its second quarter.

    • Sea (NYSE:SE) is likely to report quarterly earnings at $0.12 per share on revenue of $3.12 billion.

    • Fathom Digital Mfg (NYSE:FATH) is estimated to report quarterly loss at $1.00 per share on revenue of $32.19 million.

    • Eagle Point Income (NYSE:EIC) is expected to report earnings for its third quarter.

    • Eagle Point Credit Co (NYSE:ECC) is projected to report quarterly earnings at $0.33 per share on revenue of $33.40 million.

    • On Holding (NYSE:ONON) is expected to report quarterly earnings at $0.16 per share on revenue of $515.37 million.

    • Mondee Hldgs (NASDAQ:MOND) is projected to report quarterly loss at $0.11 per share on revenue of $65.25 million.

    • Bakkt Hldgs (NYSE:BKKT) is likely to report quarterly loss at $0.17 per share on revenue of $16.13 million.

    • Acurx Pharmaceuticals (NASDAQ:ACXP) is likely to report earnings for its third quarter.

    • Better Home & Finance (NASDAQ:BETR) is likely to report earnings for its third quarter.

    • HUYA (NYSE:HUYA) is expected to report quarterly loss at $0.03 per share on revenue of $210.33 million.

    • Generation Income (NASDAQ:GIPR) is likely to report earnings for its third quarter.

    • American Oncology Network (NASDAQ:AONC) is projected to report earnings for its third quarter.

    • NET Power (NYSE:NPWR) is expected to report quarterly loss at $0.05 per share on revenue of $1.50 million.

    • Home Depot (NYSE:HD) is projected to report quarterly earnings at $3.58 per share on revenue of $35.66 billion.

    • Antero Resources (NYSE:AR) is likely to report earnings for its third quarter.

    • Tencent Music Enter Gr (NYSE:TME) is likely to report quarterly earnings at $0.12 per share on revenue of $860.29 million.

    • Paysafe (NYSE:PSFE) is projected to report quarterly earnings at $0.07 per share on revenue of $397.33 million.

    • Terran Orbital (NYSE:LLAP) is expected to report quarterly loss at $0.19 per share on revenue of $52.14 million.

    • Vodafone Group (NASDAQ:VOD) is expected to report earnings for its first quarter.

    • Azul (NYSE:AZUL) is likely to report quarterly loss at $0.16 per share on revenue of $981.76 million.

    • Aramark (NYSE:ARMK) is expected to report quarterly earnings at $0.64 per share on revenue of $4.79 billion.

    • Energizer Hldgs (NYSE:ENR) is projected to report quarterly earnings at $1.13 per share on revenue of $796.32 million.

    • Cellebrite DI (NASDAQ:CLBT) is expected to report quarterly earnings at $0.05 per share on revenue of $82.13 million.

    • Rockwell Medical (NASDAQ:RMTI) is estimated to report quarterly loss at $0.10 per share on revenue of $22.85 million.

    • Oaktree Specialty Lending (NASDAQ:OCSL) is expected to report quarterly earnings at $0.63 per share on revenue of $103.45 million.

    Companies Reporting After The Bell

    • AmpliTech Gr (NASDAQ:AMPG) is estimated to report earnings for its third quarter.

    • ToughBuilt Industries (NASDAQ:TBLT) is expected to report quarterly loss at $0.46 per share on revenue of $29.90 million.

    • Creative Media (NASDAQ:CMCT) is likely to report quarterly loss at $0.69 per share on revenue of $30.21 million.

    • Digital Brands Group (NASDAQ:DBGI) is expected to report earnings for its third quarter.

    • CXApp (NASDAQ:CXAI) is estimated to report earnings for its third quarter.

    • Kidpik (NASDAQ:PIK) is expected to report earnings for its third quarter.

    • FlexShopper (NASDAQ:FPAY) is estimated to report quarterly loss at $0.25 per share on revenue of $24.52 million.

    • Sadot Group (NASDAQ:SDOT) is expected to report quarterly loss at $0.01 per share on revenue of $175.34 million.

    • Procaps Gr (NASDAQ:PROC) is expected to report quarterly earnings at $0.05 per share on revenue of $110.40 million.

    • Biotricity (NASDAQ:BTCY) is projected to report quarterly loss at $0.34 per share on revenue of $3.30 million.

    • Electriq Power Holdings (NYSE:ELIQ) is expected to report earnings for its third quarter.

    • Electra Battery Materials (NASDAQ:ELBM) is projected to report earnings for its third quarter.

    • Precision Optics Corp (NASDAQ:POCI) is estimated to report earnings for its first quarter.

    • Sigma Lithium (NASDAQ:SGML) is expected to report earnings for its third quarter.

    • GSE Systems (NASDAQ:GVP) is likely to report quarterly loss at $0.60 per share on revenue of $12.44 million.

    • PetVivo Hldgs (NASDAQ:PETV) is projected to report earnings for its second quarter.

    • Treasure Global (NASDAQ:TGL) is expected to report earnings for its first quarter.

    • Dolphin Entertainment (NASDAQ:DLPN) is estimated to report earnings for its third quarter.

    • Vivos Therapeutics (NASDAQ:VVOS) is expected to report earnings for its third quarter.

    • Sonder Holdings (NASDAQ:SOND) is likely to report quarterly loss at $2.97 per share on revenue of $166.31 million.

    • View (NASDAQ:VIEW) is estimated to report quarterly loss at $6.41 per share on revenue of $42.50 million.

    • VolitionRX (AMEX:VNRX) is estimated to report quarterly loss at $0.13 per share on revenue of $370 thousand.

    • Oxbridge Re Holdings (NASDAQ:OXBR) is likely to report earnings for its third quarter.

    • Arena Group Holdings (AMEX:AREN) is projected to report quarterly loss at $0.38 per share on revenue of $67.25 million.

    • Yield10 Bioscience (NASDAQ:YTEN) is projected to report quarterly loss at $0.39 per share on revenue of $70 thousand.

    • American Res (NASDAQ:AREC) is expected to report quarterly loss at $0.14 per share on revenue of $6.90 million.

    • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.36 per share on revenue of $7.65 million.

    • TOMI Environmental Solns (NASDAQ:TOMZ) is likely to report quarterly loss at $0.02 per share on revenue of $2.85 million.

    • Dada Nexus (NASDAQ:DADA) is likely to report earnings for its third quarter.

    • ENDRA Life Sciences (NASDAQ:NDRA) is projected to report earnings for its third quarter.

    • BowFlex (NYSE:BFX) is likely to report earnings for its second quarter.

    • Onconova Therapeutics (NASDAQ:ONTX) is estimated to report quarterly loss at $0.29 per share on revenue of $70 thousand.

    • Stryve Foods (NASDAQ:SNAX) is likely to report quarterly loss at $1.65 per share on revenue of $6.30 million.

    • NRX Pharmaceuticals (NASDAQ:NRXP) is likely to report earnings for its third quarter.

    • Heron Therapeutics (NASDAQ:HRTX) is likely to report quarterly loss at $0.29 per share on revenue of $32.75 million.

    • Pioneer Power Solutions (NASDAQ:PPSI) is likely to report quarterly earnings at $0.05 per share on revenue of $12.05 million.

    • Danimer Scientific (NYSE:DNMR) is expected to report quarterly loss at $0.34 per share on revenue of $14.74 million.

    • Eastside Distilling (NASDAQ:EAST) is estimated to report quarterly loss at $1.70 per share on revenue of $3.03 million.

    • CVD Equipment (NASDAQ:CVV) is likely to report earnings for its third quarter.

    • TFF Pharmaceuticals (NASDAQ:TFFP) is projected to report quarterly loss at $0.11 per share on revenue of $50 thousand.

    • Intellinetics (AMEX:INLX) is likely to report earnings for its third quarter.

    • Aytu BioPharma (NASDAQ:AYTU) is likely to report quarterly loss at $0.04 per share on revenue of $27.73 million.

    • MGO Global (NASDAQ:MGOL) is expected to report earnings for its third quarter.

    • Belite Bio (NASDAQ:BLTE) is likely to report earnings for its third quarter.

    • Capricor Therapeutics (NASDAQ:CAPR) is expected to report quarterly loss at $0.29 per share on revenue of $2.11 million.

    • Tivic Health Systems (NASDAQ:TIVC) is expected to report quarterly loss at $7.00 per share on revenue of $780 thousand.

    • Glimpse Group (NASDAQ:VRAR) is estimated to report quarterly loss at $0.18 per share on revenue of $3.00 million.

    • Inhibikase Therapeutics (NASDAQ:IKT) is expected to report earnings for its third quarter.

    • Taysha Gene Therapies (NASDAQ:TSHA) is projected to report quarterly loss at $0.17 per share on revenue of $1.32 million.

    • SHF Hldgs (NASDAQ:SHFS) is estimated to report earnings for its third quarter.

    • Asensus Surgical (AMEX:ASXC) is expected to report quarterly loss at $0.07 per share on revenue of $1.99 million.

    • Aethlon Medical (NASDAQ:AEMD) is projected to report earnings for its second quarter.

    • Inpixon (NASDAQ:INPX) is estimated to report earnings for its third quarter.

    • Polished.com (AMEX:POL) is likely to report earnings for its third quarter.

    • Natural Gas Services Gr (NYSE:NGS) is estimated to report quarterly earnings at $0.07 per share on revenue of $28.05 million.

    • Vintage Wine Estates (NASDAQ:VWE) is projected to report earnings for its first quarter.

    • Sidus Space (NASDAQ:SIDU) is likely to report quarterly loss at $0.04 per share on revenue of $1.50 million.

    • KULR Tech Gr (AMEX:KULR) is expected to report quarterly loss at $0.05 per share on revenue of $2.91 million.

    • PHAXIAM Therapeutics (NASDAQ:PHXM) is expected to report earnings for its third quarter.

    • Fluent (NASDAQ:FLNT) is projected to report quarterly loss at $0.03 per share on revenue of $79.99 million.

    • Cineverse (NASDAQ:CNVS) is projected to report quarterly loss at $0.16 per share on revenue of $15.47 million.

    • Canoo (NASDAQ:GOEV) is likely to report quarterly loss at $0.12 per share on revenue of $610 thousand.

    • Urgently (NASDAQ:ULY) is expected to report earnings for its third quarter.

    • Upexi (NASDAQ:UPXI) is likely to report quarterly loss at $0.04 per share on revenue of $26.52 million.

    • Tenon Medical (NASDAQ:TNON) is estimated to report quarterly loss at $0.28 per share on revenue of $1.07 million.

    • Cormedix (NASDAQ:CRMD) is estimated to report earnings for its third quarter.

    • PAVmed (NASDAQ:PAVM) is likely to report quarterly loss at $0.14 per share on revenue of $660 thousand.

    • Surgepays (NASDAQ:SURG) is likely to report quarterly earnings at $0.28 per share on revenue of $37.83 million.

    • Strata Skin Sciences (NASDAQ:SSKN) is projected to report quarterly loss at $0.04 per share on revenue of $8.72 million.

    • QuickLogic (NASDAQ:QUIK) is estimated to report quarterly earnings at $0.13 per share on revenue of $6.50 million.

    • WidePoint (AMEX:WYY) is estimated to report earnings for its third quarter.

    • iPower (NASDAQ:IPW) is projected to report quarterly loss at $0.06 per share on revenue of $24.30 million.

    • Addvantage Technologies (NASDAQ:AEY) is projected to report earnings for its third quarter.

    • VirTra (NASDAQ:VTSI) is estimated to report quarterly loss at $0.05 per share on revenue of $6.02 million.

    • Sarcos Technology (NASDAQ:STRC) is expected to report quarterly loss at $0.59 per share on revenue of $1.20 million.

    • ClearSign Technologies (NASDAQ:CLIR) is likely to report earnings for its third quarter.

    • Alcon (NYSE:ALC) is estimated to report quarterly earnings at $0.67 per share on revenue of $2.35 billion.

    • Ontrak (NASDAQ:OTRK) is likely to report earnings for its third quarter.

    • Super League Enterprise (NASDAQ:SLE) is estimated to report quarterly loss at $1.69 per share on revenue of $6.62 million.

    • Surf Air Mobility (NYSE:SRFM) is likely to report earnings for its third quarter.

    • IZEA Worldwide (NASDAQ:IZEA) is expected to report quarterly loss at $0.07 per share on revenue of $8.50 million.

    • Shapeways Holdings (NASDAQ:SHPW) is expected to report quarterly loss at $1.00 per share on revenue of $8.72 million.

    • HeartBeam (NASDAQ:BEAT) is expected to report earnings for its third quarter.

    • Quest Resource Holding (NASDAQ:QRHC) is likely to report quarterly earnings at $0.00 per share on revenue of $77.70 million.

    • Duos Technologies Group (NASDAQ:DUOT) is projected to report quarterly loss at $0.32 per share on revenue of $2.42 million.

    • Galiano Gold (AMEX:GAU) is estimated to report earnings for its third quarter.

    • Complete Solaria (NASDAQ:CSLR) is projected to report earnings for its third quarter.

    • Momentus (NASDAQ:MNTS) is likely to report quarterly loss at $7.09 per share on revenue of $400 thousand.

    • Intrusion (NASDAQ:INTZ) is estimated to report quarterly loss at $0.11 per share on revenue of $1.98 million.

    • Iridex (NASDAQ:IRIX) is projected to report quarterly loss at $0.12 per share on revenue of $13.48 million.

    • Getty Images Holdings (NYSE:GETY) is expected to report quarterly earnings at $0.04 per share on revenue of $228.14 million.

    • Arcturus Therapeutics (NASDAQ:ARCT) is projected to report quarterly loss at $1.69 per share on revenue of $15.86 million.

    • AST SpaceMobile (NASDAQ:ASTS) is expected to report earnings for its third quarter.

    • Gold Royalty (AMEX:GROY) is likely to report quarterly loss at $0.01 per share on revenue of $1.94 million.

    • AlTi Global (NASDAQ:ALTI) is projected to report quarterly earnings at $0.05 per share on revenue of $55.90 million.

    • Venus Concept (NASDAQ:VERO) is expected to report quarterly loss at $1.51 per share on revenue of $17.46 million.

    • GEN Restaurant Gr (NASDAQ:GENK) is expected to report quarterly earnings at $0.07 per share on revenue of $46.62 million.

    • Singular Genomics Sys (NASDAQ:OMIC) is estimated to report quarterly loss at $0.38 per share on revenue of $1.27 million.

    • Varex Imaging (NASDAQ:VREX) is estimated to report quarterly earnings at $0.35 per share on revenue of $232.33 million.

    • 10x Genomics (NASDAQ:TXG) is expected to report earnings for its third quarter.

    • Rekor Systems (NASDAQ:REKR) is projected to report quarterly loss at $0.15 per share on revenue of $10.64 million.

    • Intl General Insurance (NASDAQ:IGIC) is estimated to report quarterly earnings at $0.49 per share on revenue of $130.20 million.

    • Flexible Solutions Intl (AMEX:FSI) is estimated to report quarterly earnings at $0.09 per share on revenue of $11.93 million.

    • PSQ Holdings (NYSE:PSQH) is projected to report earnings for its third quarter.

    • Nu Holdings (NYSE:NU) is expected to report quarterly earnings at $0.06 per share on revenue of $2.02 billion.

    • Electrovaya (NASDAQ:ELVA) is projected to report earnings for its third quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $XNET alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XNET
    $YTEN
    $CVAC
    $CMCL

    CompanyDatePrice TargetRatingAnalyst
    Vipshop Holdings Limited
    $VIPS
    2/27/2026$22.00Neutral → Buy
    Nomura
    Eagle Point Income Company Inc.
    $EIC
    2/27/2026Buy → Neutral
    Ladenburg Thalmann
    Alcon Inc.
    $ALC
    2/26/2026$97.00Equal Weight → Overweight
    Wells Fargo
    Home Depot Inc.
    $HD
    2/25/2026$410.00 → $435.00Outperform
    Telsey Advisory Group
    Cineverse Corp.
    $CNVS
    2/19/2026$12.00Speculative Buy → Buy
    The Benchmark Company
    Camtek Ltd.
    $CAMT
    2/18/2026$150.00Outperform → Market Perform
    Northland Capital
    Aramark
    $ARMK
    2/17/2026$50.00Buy
    BofA Securities
    QuickLogic Corporation
    $QUIK
    2/9/2026$10.00Buy
    Lake Street
    More analyst ratings

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vipshop upgraded by Nomura with a new price target

    Nomura upgraded Vipshop from Neutral to Buy and set a new price target of $22.00

    2/27/26 9:00:21 AM ET
    $VIPS
    Catalog/Specialty Distribution
    Consumer Discretionary

    Eagle Point Income Company downgraded by Ladenburg Thalmann

    Ladenburg Thalmann downgraded Eagle Point Income Company from Buy to Neutral

    2/27/26 8:28:05 AM ET
    $EIC
    Finance/Investors Services
    Finance

    Alcon upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Alcon from Equal Weight to Overweight and set a new price target of $97.00

    2/26/26 7:10:22 AM ET
    $ALC
    Ophthalmic Goods
    Health Care

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Duos Technologies Group, Inc. Signs ~$200M LOI and Appoints Doug Recker as CEO

    3-Year NVIDIA GPU hosting LOI delivers $40M+ annual EBITDA 10MW site secured to accelerate expansion of distributed AI infrastructure in 2026  JACKSONVILLE, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT) has signed a non-binding letter of intent ("LOI") with Hydra Host to deploy a high-density NVIDIA GPU cluster for a leading global technology customer. The project supports an underlying GPU-as-a-Service ("GPUaas") partnership that is expected to generate approximately $176 million in revenue over a 36-month term. The deployment is modeled to support gross margins more than 80% and projected annual EBITDA exceeding $40 million

    2/27/26 8:30:00 AM ET
    $DUOT
    Computer Software: Prepackaged Software
    Technology

    ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC

    • EORTC Recurrence Score Analysis from the Pivotal ENVISION Trial to be Presented at the 2026 American Society of Clinical Oncology's Genitourinary Cancers Symposium (ASCO-GU 2026) PRINCETON, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative, non-surgical therapies for urothelial and specialty cancers, today announced new post-hoc analyses from the Phase 3 ENVISION trial showing that ZUSDURI™ (mitomycin) for intravesical solution (formerly known as UGN-102) achieved durable complete response (CR) rates across European Organization for Research and Treatment of Cancer (EORTC) recurrence score g

    2/27/26 8:30:00 AM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bakkt Announces Pricing of $48.125 Million Registered Direct Offering

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today announced the pricing of a registered direct offering of 3,024,799 shares of Class A common stock and pre-funded warrants to purchase up to 2,475,201 shares of Class A common stock at a price of $8.75 per share and $8.7499 per pre-funded warrant, which represents the per share price of each share of Class A common stock less the $0.0001 per share exercise price for each pre-funded warrant. The offering to a single institutional investor is expected to close on or around March 2, 2026, subject to customary closing conditions. The gross proceeds from the offering, before deducting placement a

    2/27/26 7:32:49 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,950 worth of shares (3,000 units at $1.65), increasing direct ownership by 0.68% to 440,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/24/26 7:08:09 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Director Gordon Gary B. bought $40,000 worth of shares (9,756 units at $4.10) (SEC Form 4)

    4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)

    2/23/26 4:08:23 PM ET
    $TLSI
    Medical Specialities
    Health Care

    Chief Financial Officer Patience David bought $14,994 worth of shares (3,657 units at $4.10), increasing direct ownership by 1% to 268,657 units (SEC Form 4)

    4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)

    2/23/26 4:08:30 PM ET
    $TLSI
    Medical Specialities
    Health Care

    $XNET
    $YTEN
    $CVAC
    $CMCL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel and Secretary D'Annunzio Marc sold $7,924 worth of shares (785 units at $10.09), decreasing direct ownership by 0.66% to 117,833 units (SEC Form 4)

    4 - Bakkt, Inc. (0001820302) (Issuer)

    2/27/26 5:49:38 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    New insider Bvf Partners L P/Il claimed ownership of 7,590,690 shares (SEC Form 3)

    3 - IMMUNIC, INC. (0001280776) (Issuer)

    2/27/26 5:03:09 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Nagel Robert Thorvald

    3 - IMMUNIC, INC. (0001280776) (Issuer)

    2/27/26 5:00:26 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XNET
    $YTEN
    $CVAC
    $CMCL
    SEC Filings

    View All

    Tenon Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Tenon Medical, Inc. (0001560293) (Filer)

    2/27/26 4:30:25 PM ET
    $TNON
    Medical/Dental Instruments
    Health Care

    Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits

    8-K - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Filer)

    2/27/26 4:24:56 PM ET
    $BCLI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form POS AM filed by Strata Skin Sciences Inc.

    POS AM - STRATA Skin Sciences, Inc. (0001051514) (Filer)

    2/27/26 4:04:44 PM ET
    $SSKN
    Medical/Dental Instruments
    Health Care

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Leadership Updates

    Live Leadership Updates

    View All

    Duos Technologies Group, Inc. Signs ~$200M LOI and Appoints Doug Recker as CEO

    3-Year NVIDIA GPU hosting LOI delivers $40M+ annual EBITDA 10MW site secured to accelerate expansion of distributed AI infrastructure in 2026  JACKSONVILLE, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT) has signed a non-binding letter of intent ("LOI") with Hydra Host to deploy a high-density NVIDIA GPU cluster for a leading global technology customer. The project supports an underlying GPU-as-a-Service ("GPUaas") partnership that is expected to generate approximately $176 million in revenue over a 36-month term. The deployment is modeled to support gross margins more than 80% and projected annual EBITDA exceeding $40 million

    2/27/26 8:30:00 AM ET
    $DUOT
    Computer Software: Prepackaged Software
    Technology

    Paysafe Announces Changes to its Board of Directors

    New appointments bring deep expertise in global payments, digital transformation, marketing, and product innovation Paysafe (NYSE:PSFE), a leading payments platform, today announced the appointment of four new non‑executive directors to its Board, effective February 26, 2026. The new directors bring extensive expertise across global payments, financial services, technology, product innovation, and marketing leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227922419/en/Rupert Keeley Rupert Keeley Rupert Keeley brings significant strategic payments expertise and global regulatory insight to Paysafe. His decades of

    2/27/26 7:00:00 AM ET
    $PSFE
    Real Estate

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Stock Movement: Insider Purchase at AlTi Global Inc. on Jun 5

    On June 5, 2024, **Tiedemann Michael** made a significant purchase of **47,373** units of **AlTi Global Inc.** shares at a price of **$4.86** per share, amounting to a total investment of **$230,460**. This transaction led to a **10%** increase in his direct ownership of the company's shares, bringing his total holding to **499,887** units. This insider purchase was disclosed in the **SEC Form 4** filing. Interestingly, this purchase follows a series of other notable transactions by **Tiedemann Michael** in the past month. On May 21, 2024, he acquired **100,000** units of shares at **$4.61** each, increasing his direct ownership by **32%** to **409,146** units. Just two days later, on May 23

    6/10/24 1:07:48 AM ET
    $ALTI
    Investment Managers
    Finance

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Better Home & Finance Holding Company

    SC 13D/A - Better Home & Finance Holding Co (0001835856) (Subject)

    12/17/24 8:40:06 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Natural Gas Services Group Inc.

    SC 13D/A - NATURAL GAS SERVICES GROUP INC (0001084991) (Subject)

    12/13/24 6:13:02 PM ET
    $NGS
    Oilfield Services/Equipment
    Energy

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    $XNET
    $YTEN
    $CVAC
    $CMCL
    Financials

    Live finance-specific insights

    View All

    Surf Air Mobility to Announce Fourth Quarter and Year-end 2025 Financial Results on March 12, 2026

    Surf Air Mobility Inc. (NYSE:SRFM) a leading air mobility platform, today announced that it will release its fourth quarter and year-end 2025 financial results after market close on Thursday, March 12, 2026, and will host a webcast at 5:00 pm ET the same day. Interested parties can register in advance to listen to the webcast here or can find a link on the ‘Events & Presentations' section of our investor relations website. Alternatively, listeners may dial into the call as follows: North America - Toll-Free (800) 715-9871 International (Toll) - (646) 307-1963 Conference ID: 4775356 About Surf Air Mobility Surf Air Mobility is a Los Angeles-based air mobility platform. With its AI-en

    2/26/26 4:05:00 PM ET
    $SRFM
    Transportation Services
    Consumer Discretionary

    Quest Resource Holding Corporation to Report Fourth Quarter and Full Year 2025 Financial Results and Host Earnings Call on March 12, 2026

    THE COLONY, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ:QRHC) ("Quest" or the "Company"), a national leader in environmental waste and recycling services, today announced that it will release results for its fourth quarter and year ended December 31, 2025, on Thursday, March 12, 2026, after market close. Management will host a conference call that same day at 5:00 PM ET to review the Company's financial results and business outlook. Investors interested in participating in the live call can dial 1-800-717-1738 or 1-646-307-1865. Investors can also access the call online through a listen-only webcast on the investor relations section of Quest's websi

    2/26/26 4:05:00 PM ET
    $QRHC
    Environmental Services
    Utilities

    Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

    – ZYNRELEF® and APONVIE® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise– Achieved $154.9 Million in 2025 Net Revenue– Issues Full-Year 2026 Net Revenue Guidance of $173 to $183 Million and Adjusted EBITDA of $10 to $20 Million CARY, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three and twelve months ended December 31, 2025, and highlighted recent corporate updates. "As demonstrated in today's release, we are entering 2026 with exceptional momentum. The fourth quarter delivered the strongest results in the history of He

    2/26/26 8:00:00 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care